Cargando…
Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma
In diffuse large B-cell lymphoma (DLBCL), many oncogenic microRNAs (OncomiRs) are highly expressed to promote disease development and progression by inhibiting the expression and function of certain tumor suppressor genes, and these OncomiRs comprise a promising new class of molecular targets for th...
Autores principales: | Su, Yinghan, Sun, Bin, Lin, Xuejing, Zhao, Xinying, Ji, Weidan, He, Miaoxia, Qian, Haihua, Song, Xianmin, Yang, Jianmin, Wang, Jianmin, Chen, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226497/ https://www.ncbi.nlm.nih.gov/pubmed/27172795 http://dx.doi.org/10.18632/oncotarget.9237 |
Ejemplares similares
-
HBV infection potentiates resistance to S-phase arrest-inducing chemotherapeutics by inhibiting CHK2 pathway in diffuse large B-cell lymphoma
por: Zhao, Xinying, et al.
Publicado: (2018) -
Clinical Significance of “Double-hit” and “Double-protein” expression in Primary Gastric B-cell Lymphomas
por: He, Miaoxia, et al.
Publicado: (2016) -
Artemether suppresses cell proliferation and induces apoptosis in diffuse large B cell lymphoma cells
por: Zhao, Xinying, et al.
Publicado: (2017) -
LncRNA-RMRP Acts as an Oncogene in Lung Cancer
por: Meng, Qingjun, et al.
Publicado: (2016) -
Survival-Related lncRNA Landscape Analysis Identifies LINC01614 as an Oncogenic lncRNA in Gastric Cancer
por: Wu, Huijie, et al.
Publicado: (2021)